COPD
Or Chronic Bronchitis That Was
Dr Bruce Davies
Possible Areas to Cover
• Diagnosis
• Initial investigation
• Management plans
• Referral criteria
• Follow plans
• Troubleshooting
• The evidence base
Possible Areas to Cover
• Ideas for Audit
• Sources of further information
• Case Histories
• Future developments
• Prevalence
• Risk factors
• Prevention
Labels encompassed by COPD
• Chronic bronchitis
• Emphysema
• COAD
• Chronic airflow restriction
• Some cases of chronic asthma
Definition
• Chronic slowly progressive airways obstruction, not fully reversible
• FEV1 <80% predicted
• FEV1/FVC ratio <70%
• Impairment largely fixed
Prevalence
• Depends on where you work!• Male:Female = 4:1• Urban:Rural = 2:1• 5-25% of population• Declining, or being redefined!• 1-4 consultations per GP per week• Strongly social class related• Increases with age
Risk Factors
• Smoking
• Asthma
• Genetic
• Social class (Independent ? Of other factors)
• Pollution
• Occupational dust exposure
• Recurrent infection
Symptoms
• “Smokers cough” - Mild
• Breathlessness on exertion - Moderate
• Cough +/- sputum - Moderate
• Breathlessness on any exertion - Severe
• Peripheral oedema - Severe
Diagnosis
• Spirometry preferred to PEFR
• If PEFR used then it needs to be done over several weeks to confirm lack of variability
• CXR to exclude other problems
• Bronchodilators only give limited improvement of PEF
Management Plans
Essential at all stages
Quit rates improved by:
I. Active cessation programmes
II. NRT
Management Plans
Exercise.
Encouraged where at all possible, evidence that graded programmes are beneficial is growing.
Management Plans
• Obesity and poor nutrition make things worse
Management Plans
Depression• Common concurrent
problem
Social problems• Also common
Management Plans
Vaccination
Influenza for all
? Pneumococcal
Management Plans
i. Short acting Bronchodilator PRN
or
Anticholinergic MDI, PRN
ii. Regular use of above
iii. Combination of two
Management Plans
ii. ? Steroid trial
iii. ? Regular inhaled steroid, if positive response to trial
iv. Assess for home nebuliser
v. Assess for LTOT
Management Plans
Probably useless• Xanthines• Long acting beta
agonists
Steroid Trial
30mg prednisolone daily for 2 weeks
• + = 200ml increase in FEV1 from baseline
• Subjective improvement is negative
• Objective improvement in 10-20%
Referral Criteria
• Suspected severe COPD To confirm diagnosis & optimise therapy
• Onset of Cor pulmonale To confirm diagnosis & optimise therapy
• ? Need for oxygen therapy To measure blood gasses
Referral Criteria
• ? Nebuliser therapy To exclude inappropriate prescriptions
• Assessment for oral steroids To justify long term use / withdrawal supervision
• Bullous lung disease ? Surgery
Referral Criteria
• <10 pack years of smoking To confirm or exclude the diagnosis
• Rapid decline in FEV1 To encourage early intervention
• Aged less than 40 ? Alpha 1 anti-trypsin deficiency
Referral Criteria
• Uncertain diagnosisTo make one!
• Symptoms disproportionate to lung functionTo look for other explanations
Acute Exacerbations
Or
Help
Features
• Worsening of previously stable state
• Increased dyspnoea
• Chest tightness
• Fluid retention
• Increased wheeze
• Increased sputum
• Increased sputum purulence
Assessment
• Able to cope at home?• Good social circumstances?• Cyanosis?• Consciousness?• Degree of breathlessness• General condition?• LTOT?• Level of activity?
Home Treatment
a. Increase bronchodilators
b. 7 day course of Abxc. Steroids for 1 week
Consider: CXR, admission or referral if not back to “normal” in 2 weeks
Other Stuff
Evidence ?
• Rather good for these suggestions
• Very much a EBM field
• British Thoracic Society
References
• Thorax, 1997; 52(suppl 5): S1-S32
• Common Diseases, Fry, MTP, 1995.
Prevention
• Fags
• Fags
• Fags
• Pollution
• Occupational factors
• ? Housing
Questions
• Should practices have spirometers?
• Or open access to lung function clinics?
• Should practice nurses run regular follow-up clinics?
• How should a practice audit this area?
• Should practices have smoking cessation clinics?